Appendix: expert paper

Détails

ID Serval
serval:BIB_EC2325071E7D
Type
Partie de livre
Sous-type
Chapitre: chapitre ou section
Collection
Publications
Institution
Titre
Appendix: expert paper
Titre du livre
Nanotechnology: balancing benefits and risks to public health and the environment
Auteur⸱e⸱s
Feitshans Ilise L.
Editeur
Sudarenkov Valeriy
Lieu d'édition
Council of Europe, Parliamentary Assembly
Statut éditorial
Publié
Date de publication
2012
Pages
6-21
Langue
anglais
Résumé
Nanotechnology has been heralded as a "revolution" in science, for two reasons: first, because of its revolutionary view of the way in which chemicals and elements, such as gold and silver, behave, compared to traditional scientific understanding of their properties. Second, the impact of these new discoveries, as applied to commerce, can transform the daily life of consumer products ranging from sun tan lotions and cosmetics, food packaging and paints and coatings for cars, housing and fabrics, medicine and thousands of industrial processes.9 Beneficial consumer use of nanotechnologies, already in the stream of commerce, improves coatings on inks and paints in everything from food packaging to cars.
Additionally, "Nanomedicine" offers the promise of diagnosis and treatment at the molecular level in order to detect and treat presymptomatic disease,10 or to rebuild neurons in Alzheimer's and Parkinson's disease. There is a possibility that severe complications such as stroke or heart attack may be avoided by means of prophylactic treatment of people at risk, and bone regeneration may keep many people active who never expected rehabilitation. Miniaturisation of diagnostic equipment can also reduce the amount of sampling materials required for testing and medical surveillance.
Miraculous developments, that sound like science fiction to those people who eagerly anticipate these medical products, combined with the emerging commercial impact of nanotechnology applications to consumer products will reshape civil society - permanently. Thus, everyone within the jurisdiction of the Council of Europe is an end-user of nanotechnology, even without realising that nanotechnology has touched daily life.
Mots-clé
Nanotechnology , Health , Jurisprudence , Commerce
Création de la notice
18/01/2013 14:23
Dernière modification de la notice
20/08/2019 17:14
Données d'usage